P0126 Cytolytic virus activation therapy for epstein-barr virus driven tumours by Greijer, A.E, Stoker, S.D, Novalic, Z, Malik, O, Verkuijlen, S.A.W.M, Juwana, H, Huitema, A.D.R, Tan, B.I, de Boer, J.P, Hutajulu, S.H, Kurnianda, J, Middeldorp, J.M

Get full text

O.5.7 Detailed characterisation of Epstein–Barr virus (EBV) infected cells in the circulation of organ transplant recipients with persistent high EBV DNA loads by Greijer, A.E, Stevens, S.J, Verkuijlen, S.A.W.M, Juwana, H, Fleig, S.C, Verschuuren, E.A.M, Hepkema, B.G, Middeldorp, J.M

Get full text

Quantitative multi-target RNA profiling in Epstein-Barr virus infected tumor cells by Greijer, A.E., Ramayanti, O., Verkuijlen, S.A.W.M., Novalić, Z., Juwana, H., Middeldorp, J.M.

Get full text

Role of Epstein-Barr Virus DNA Load Monitoring in Prevention and Early Detection of Post-transplant Lymphoproliferative Disease by Stevens, Servi J.C., Verschuuren, Erik A.M., Verkuijlen, Sandra A.W.M., van den Brule, Adriaan J.C., Meijer, Chris J.L.M., Middeldorp, Jaap M.

Get full text

Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas by Ramayanti, Octavia, Brinkkemper, Mitch, Verkuijlen, Sandra A W M, Ritmaleni, Leni, Go, Mei Lin, Middeldorp, Jaap M

Get full text